Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2012.0201


Whole-genome sequence: from research to clinical practice?

Dimosthenis Ziogas, MD, PhD

Affiliation: Dimosthenis Ziogas MD, PhD, Dept. of Surgery, University of Ioannina, School of Medicine, 45110 Ioannina, Greece.


The advent of next-generation sequencing (NGS) technologies has provided unprecedented powerful unbiased research on genomics, transcriptomics, epigenomics and chromatin remodeling. This characterization of these complex interacting systems provides the first steps towards understanding gen expression regulatory networks. The ability of NGS device for whole-genome sequencing for identifying all kinds of mutations –SNPs, insertions, deletions, copy-number changes, translocations- simultaneously, faster, cheaper and more accurate than traditional Sanger DNA sequencing has made it very popular. The evolution of this massively parallel sequencing platform is so rapid that the first applications in clinical medicine and cancer treatment have already been reported. In this perspective article, the potential prescription of NGS-based exome and whole-genome in routine clinical practice is discussed.

(Citation: Gastric & Breast Cancer 2012; 11(1): 7-12)



You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 28 December 2011